Sílvia Stanisçuaski Guterres Selected Research

Nanocapsules

12/2021	Oral delivery of ambrisentan-loaded lipid-core nanocapsules as a novel approach for the treatment of pulmonary arterial hypertension.
5/2021	Resveratrol-Loaded Lipid-Core Nanocapsules Modulate Acute Lung Inflammation and Oxidative Imbalance Induced by LPS in Mice.
12/2020	Intranasal administration of budesonide-loaded nanocapsule microagglomerates as an innovative strategy for asthma treatment.
10/2020	Semi-Mechanistic Pharmacokinetic Modeling of Lipid Core Nanocapsules: Understanding Quetiapine Plasma and Brain Disposition in a Neurodevelopmental Animal Model of Schizophrenia.
7/2020	(-)-linalool-Loaded Polymeric Nanocapsules Are a Potential Candidate to Fibromyalgia Treatment.
6/2020	Phenytoin-loaded lipid-core nanocapsules improve the technological properties and in vivo performance of fluidised bed granules.
1/2020	Quetiapine lipid core nanocapsules restore prepulse inhibition deficits in a neurodevelopmental model of schizophrenia in male and female rats.
3/2019	Chitosan hydrogels containing nanoencapsulated phenytoin for cutaneous use: Skin permeation/penetration and efficacy in wound healing.
1/2019	Lapatinib-Loaded Nanocapsules Enhances Antitumoral Effect in Human Bladder Cancer Cell.
11/2018	Reconstituted spray-dried phenytoin-loaded nanocapsules improve the in vivo phenytoin anticonvulsant effect and the survival time in mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sílvia Stanisçuaski Guterres Research Topics

Disease

4	Wounds and Injuries (Trauma) 03/2019 - 10/2013
3	Neoplasms (Cancer) 01/2020 - 02/2013
3	Glioma (Gliomas) 01/2020 - 02/2013
2	Schizophrenia (Dementia Praecox) 10/2020 - 01/2020
2	Seizures (Absence Seizure) 06/2020 - 11/2018
2	Burns 11/2016 - 05/2015
1	Pulmonary Arterial Hypertension 12/2021
1	Infections 07/2021
1	Cryptococcosis 07/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2021
1	Acute Lung Injury 05/2021
1	Lung Injury 05/2021
1	Pneumonia (Pneumonitis) 05/2021
1	Allergic Rhinitis 12/2020
1	Asthma (Bronchial Asthma) 12/2020
1	Rhinitis 12/2020
1	Fibromyalgia (Fibrositis) 07/2020
1	Cutaneous Leishmaniasis 01/2020
1	Parasitic Diseases (Parasitic Disease) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2019
1	Epilepsy (Aura) 03/2019
1	Gingival Hyperplasia 03/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Heart Failure 05/2017
1	Hypertension (High Blood Pressure) 05/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2017
1	Venous Insufficiency 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Brain Diseases (Brain Disorder) 01/2017
1	Cicatrix (Scar) 11/2016
1	Mucopolysaccharidosis I (Hurler Syndrome) 03/2015
1	Toxoplasmosis 02/2014
1	Ulcer 05/2010
1	Osteoporosis 05/2010

Drug/Important Bio-Agent (IBA)

13	NanocapsulesIBA 12/2021 - 02/2013
9	LipidsIBA 12/2021 - 02/2013
5	Pharmaceutical PreparationsIBA 11/2018 - 02/2013
3	PowdersIBA 12/2020 - 11/2018
3	Anticonvulsants (Antiepileptic Drugs)IBA 06/2020 - 11/2018
2	Quetiapine Fumarate (Seroquel)FDA Link 10/2020 - 01/2020
2	CurcuminIBA 08/2019 - 02/2013
2	ChitosanIBA 03/2019 - 11/2018
2	usnic acidIBA 11/2016 - 05/2015
1	ambrisentan FDA Link 12/2021
1	Amiodarone (Amiodarona)FDA LinkGeneric 07/2021
1	Fluconazole (Zonal)FDA LinkGeneric 07/2021
1	CalciumIBA 07/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 07/2021
1	AntioxidantsIBA 05/2021
1	ResveratrolIBA 05/2021
1	Therapeutic UsesIBA 05/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 12/2020
1	ChemokinesIBA 12/2020
1	Budesonide (Pulmicort)FDA LinkGeneric 12/2020
1	Chemokine CCL11IBA 12/2020
1	linaloolIBA 07/2020
1	Poly I-CIBA 01/2020
1	Phenytoin (Dilantin)FDA LinkGeneric 03/2019
1	HydrogelsIBA 03/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	Pilocarpine (Ocusert)FDA LinkGeneric 11/2018
1	Carvedilol (Coreg)FDA LinkGeneric 05/2017
1	bisabolol (levomenol)IBA 01/2017
1	hesperetinIBA 01/2017
1	CholesterolIBA 01/2017
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	CollagenIBA 11/2016
1	Liposomes (Liposome)IBA 11/2016
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 11/2016
1	GelatinIBA 11/2016
1	Ointments (Pastes)IBA 11/2016
1	Sunscreening Agents (Sunscreens)IBA 05/2015
1	Pyrimethamine (Daraprim)FDA Link 02/2014
1	Thioctic Acid (Lipoic Acid)IBA 10/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2013
1	SodiumIBA 05/2010
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 05/2010

Therapy/Procedure

3	Oral Administration 12/2021 - 05/2010
2	Therapeutics 07/2021 - 05/2021
2	Intranasal Administration 12/2020 - 01/2020
1	Injections 01/2020
1	Off-Label Use 03/2019
1	Secondary Prevention 01/2017